Jia-li Kang — Endo Lab

article 2009

Efficacy of Gonadotropin-Releasing Hormone Agonist and an Extended-Interval Dosing Regimen in the Treatment of Patients with Adenomyosis and Endometriosis

Gynecologic and obstetric investigation ·doi:10.1159/000258683

AIMS: To determine the effects of gonadotropin-releasing hormone agonist (GnRH-a) and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometriosis. METHODS: This was a prospective observational study i…

article 2008

Effect of gonadotropin releasing hormone analogues on apoptosis of cultured adenomyosis endometrial cells

·doi:10.3760/cma.j.issn.1674-1927.2008.05.008

Objective To investigate the effects of gonadotropin releasing hormone analogues (GnRHa) on apoptosis of cultured adenomyosis (AM) endometrial cells. Methods Eutopic endometrial cells from 32 women who received hysterectomy for AM (study gr…

article 2007

Expression of Bcl-2 protein, Ki-67 antigen, ER and PR in endometrium of human adenomyosis

·doi:10.3760/cma.j.issn.1674-1927.2007.04.002

Objective To examine the expression of cell apoptosis repressor factor, Bcl-2 protein, celluar nucleus related antigen, Ki-67 antigen, estrogen receptor (ER) and progesterone receptor ( PR ) in eutopic and ectopic endometrium of adenomyosis…

article 2006

The study of E-cadherin and CD44 varient 6 on pathogenesis in human adenomyosis

·doi:10.3877/cma.j.issn.1673-5250.2006.06.104

Objective To observe the expression of E-cadherin and CD44 v6 in human adenomyosis.To explore the correlation between the expression of E-cadherin and CD44 v6 in the pathogenesis of adenomyosis. Methods The expression of E-cadherin a…